D68.52Billable
Prothrombin gene mutation
Chapter 2: Neoplasms
Billable Code
D68.52 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Additional Information from Parent Codes
The following information may apply to this code from its parent codes in the ICD-10 hierarchy. This information is important for proper coding and classification.
Parent Codes Referenced:
Inclusion Terms
1 item
Inclusion Terms
From D68.5:
- •Primary hypercoagulable states
Excludes1
10 items
Excludes1
From D68.5:
- •antiphospholipid syndrome (D68.61)
- •lupus anticoagulant (D68.62)
- •secondary activated protein C resistance (D68.69)
- •secondary antiphospholipid antibody syndrome (D68.69)
- •secondary lupus anticoagulant with hypercoagulable state (D68.69)
- •secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
- •systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
- •systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
- •thrombotic thrombocytopenic purpura (M31.19)
Notes
8 items
Notes
From C00-D49:
- •Functional activity
- •All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- •Morphology [Histology]
- •Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- •Primary malignant neoplasms overlapping site boundaries
- •A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- •Malignant neoplasm of ectopic tissue
- •Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).